Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

September 10, 2012

SARATOGA ADVANTAGE TRUST HEALTH & BIOTECHNOLOGY PORTFOLIO v. PAR PHARMACEUTICAL COMPANIES, INC. et al

Track this case

Case Number:

2:12-cv-05652

Court:

New Jersey

Nature of Suit:

Stockholders Suits

Multi Party Litigation:

Class Action

Judge:

Stanley R. Chesler

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 12, 2012

    TPG's $2B Par Pharma Buyout Bid Harms Investors, Suit Says

    A Par Pharmaceutical Cos. Inc. shareholder launched a class action Wednesday challenging private equity firm TPG Capital's $1.9 billion bid to take the generic-drug maker private, saying the deal was based on a flawed process favoring TPG and Par.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login